These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31069381)

  • 1. Phase 1 Safety, Pharmacokinetics, and Fluorescence Imaging Study of Tozuleristide (BLZ-100) in Adults With Newly Diagnosed or Recurrent Gliomas.
    Patil CG; Walker DG; Miller DM; Butte P; Morrison B; Kittle DS; Hansen SJ; Nufer KL; Byrnes-Blake KA; Yamada M; Lin LL; Pham K; Perry J; Parrish-Novak J; Ishak L; Prow T; Black K; Mamelak AN
    Neurosurgery; 2019 Oct; 85(4):E641-E649. PubMed ID: 31069381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time Visualization of Breast Carcinoma in Pathology Specimens From Patients Receiving Fluorescent Tumor-Marking Agent Tozuleristide.
    Dintzis SM; Hansen S; Harrington KM; Tan LC; Miller DM; Ishak L; Parrish-Novak J; Kittle D; Perry J; Gombotz C; Fortney T; Porenta S; Hales L; Calhoun KE; Anderson BO; Javid SH; Byrd DR
    Arch Pathol Lab Med; 2019 Sep; 143(9):1076-1083. PubMed ID: 30550350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpected Binding of Tozuleristide "Tumor Paint" to Cerebral Vascular Malformations: A Potentially Novel Application of Fluorescence-Guided Surgery.
    Kobets AJ; Nauen D; Lee A; Cohen AR
    Neurosurgery; 2021 Jul; 89(2):204-211. PubMed ID: 33826729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonclinical Profile of BLZ-100, a Tumor-Targeting Fluorescent Imaging Agent.
    Parrish-Novak J; Byrnes-Blake K; Lalayeva N; Burleson S; Fidel J; Gilmore R; Gayheart-Walsten P; Bricker GA; Crumb WJ; Tarlo KS; Hansen S; Wiss V; Malta E; Dernell WS; Olson JM; Miller DM
    Int J Toxicol; 2017; 36(2):104-112. PubMed ID: 28403743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients.
    Yamada M; Miller DM; Lowe M; Rowe C; Wood D; Soyer HP; Byrnes-Blake K; Parrish-Novak J; Ishak L; Olson JM; Brandt G; Griffin P; Spelman L; Prow TW
    Contemp Clin Trials Commun; 2021 Sep; 23():100830. PubMed ID: 34401600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.
    Chohan MO; Berger MS
    J Neurooncol; 2019 Feb; 141(3):517-522. PubMed ID: 30097823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-infrared imaging of brain tumors using the Tumor Paint BLZ-100 to achieve near-complete resection of brain tumors.
    Butte PV; Mamelak A; Parrish-Novak J; Drazin D; Shweikeh F; Gangalum PR; Chesnokova A; Ljubimova JY; Black K
    Neurosurg Focus; 2014 Feb; 36(2):E1. PubMed ID: 24484247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative Near-Infrared Optical Imaging Can Localize Gadolinium-Enhancing Gliomas During Surgery.
    Lee JY; Thawani JP; Pierce J; Zeh R; Martinez-Lage M; Chanin M; Venegas O; Nims S; Learned K; Keating J; Singhal S
    Neurosurgery; 2016 Dec; 79(6):856-871. PubMed ID: 27741220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase 1 Dose-Escalation Study of Oral 5-Aminolevulinic Acid in Adult Patients Undergoing Resection of a Newly Diagnosed or Recurrent High-Grade Glioma.
    Cozzens JW; Lokaitis BC; Moore BE; Amin DV; Espinosa JA; MacGregor M; Michael AP; Jones BA
    Neurosurgery; 2017 Jul; 81(1):46-55. PubMed ID: 28498936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
    Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
    J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence Identification of Head and Neck Squamous Cell Carcinoma and High-Risk Oral Dysplasia With BLZ-100, a Chlorotoxin-Indocyanine Green Conjugate.
    Baik FM; Hansen S; Knoblaugh SE; Sahetya D; Mitchell RM; Xu C; Olson JM; Parrish-Novak J; Méndez E
    JAMA Otolaryngol Head Neck Surg; 2016 Apr; 142(4):330-8. PubMed ID: 26892902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering microglia as intraoperative optical imaging agent vehicles potentially for fluorescence-guided surgery in gliomas.
    Guo L; Zhang X; Wei R; Li G; Sun B; Zhang H; Liu D; Wang C; Feng M
    Biomater Sci; 2020 Feb; 8(4):1117-1126. PubMed ID: 31724666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-Infrared Imaging with Second-Window Indocyanine Green in Newly Diagnosed High-Grade Gliomas Predicts Gadolinium Enhancement on Postoperative Magnetic Resonance Imaging.
    Cho SS; Salinas R; De Ravin E; Teng CW; Li C; Abdullah KG; Buch L; Hussain J; Ahmed F; Dorsey J; Mohan S; Brem S; Singhal S; Lee JYK
    Mol Imaging Biol; 2020 Oct; 22(5):1427-1437. PubMed ID: 31712948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience.
    Haider SA; Lim S; Kalkanis SN; Lee IY
    J Neurooncol; 2019 Feb; 141(3):507-515. PubMed ID: 30506501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.
    Fueger BJ; Czernin J; Cloughesy T; Silverman DH; Geist CL; Walter MA; Schiepers C; Nghiemphu P; Lai A; Phelps ME; Chen W
    J Nucl Med; 2010 Oct; 51(10):1532-8. PubMed ID: 20847166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the sodium fluorescein yellow fluorescence boundary and the actual boundary of high-grade gliomas during surgical resection.
    Chen ZB; Zhu XP; Zheng W; Xiang Y; Huang YK; Fang HJ; Deng AJ; Yi FR; Chen HW; Han DQ; Lv SQ
    Br J Neurosurg; 2024 Aug; 38(4):825-832. PubMed ID: 34542381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence-Guided Surgery for High-Grade Gliomas: State of the Art and New Perspectives.
    Palmieri G; Cofano F; Salvati LF; Monticelli M; Zeppa P; Perna GD; Melcarne A; Altieri R; La Rocca G; Sabatino G; Barbagallo GM; Tartara F; Zenga F; Garbossa D
    Technol Cancer Res Treat; 2021; 20():15330338211021605. PubMed ID: 34212784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma.
    Mamelak AN; Rosenfeld S; Bucholz R; Raubitschek A; Nabors LB; Fiveash JB; Shen S; Khazaeli MB; Colcher D; Liu A; Osman M; Guthrie B; Schade-Bijur S; Hablitz DM; Alvarez VL; Gonda MA
    J Clin Oncol; 2006 Aug; 24(22):3644-50. PubMed ID: 16877732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial.
    Zhou Q; van den Berg NS; Rosenthal EL; Iv M; Zhang M; Vega Leonel JCM; Walters S; Nishio N; Granucci M; Raymundo R; Yi G; Vogel H; Cayrol R; Lee YJ; Lu G; Hom M; Kang W; Hayden Gephart M; Recht L; Nagpal S; Thomas R; Patel C; Grant GA; Li G
    Theranostics; 2021; 11(15):7130-7143. PubMed ID: 34158840
    [No Abstract]   [Full Text] [Related]  

  • 20. Elucidating the kinetics of sodium fluorescein for fluorescence-guided surgery of glioma.
    Folaron M; Strawbridge R; Samkoe KS; Serafini CE; Roberts DW; Davis SC
    J Neurosurg; 2019 Sep; 131(3):724-734. PubMed ID: 30192200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.